Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PGNX

Progenics Pharmaceuticals (PGNX) Stock Price, News & Analysis

Progenics Pharmaceuticals logo

About Progenics Pharmaceuticals Stock (NASDAQ:PGNX)

Advanced Chart

Key Stats

Today's Range
$3.94
$4.79
50-Day Range
$4.10
$4.10
52-Week Range
$1.89
$6.37
Volume
34.93 million shs
Average Volume
1.16 million shs
Market Capitalization
$355.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PGNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Progenics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PGNX Stock News Headlines

PGNX_old Historical Data
Investing in Pharmaceutical Stocks
Buffett to put 90% of his money in this one stock?
CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%.
I've Got an Options Bandage for a Sick Economy
See More Headlines

PGNX Stock Analysis - Frequently Asked Questions

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) posted its earnings results on Thursday, May, 7th. The biotechnology company reported ($0.19) earnings per share for the quarter, beating analysts' consensus estimates of ($0.22) by $0.03. The biotechnology company earned $6.25 million during the quarter. Progenics Pharmaceuticals had a negative trailing twelve-month return on equity of 129.46% and a negative net margin of 180.28%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Progenics Pharmaceuticals investors own include Synergy Pharmaceuticals (SGYP), Caterpillar (CAT), Exelixis (EXEL), IMAX (IMAX), Bristol Myers Squibb (BMY), Novavax (NVAX) and Citius Pharmaceuticals (CTXR).

Company Calendar

Last Earnings
5/07/2020
Today
8/01/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:PGNX
CIK
835887
Fax
N/A
Employees
79
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.80)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$68.55 million
Net Margins
-180.28%
Pretax Margin
N/A
Return on Equity
-129.46%
Return on Assets
-53.23%

Debt

Debt-to-Equity Ratio
0.99
Current Ratio
2.12
Quick Ratio
2.12

Sales & Book Value

Annual Sales
$34.99 million
Price / Sales
10.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.54 per share
Price / Book
7.59

Miscellaneous

Outstanding Shares
86,597,000
Free Float
N/A
Market Cap
$355.05 million
Optionable
Optionable
Beta
1.89
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:PGNX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners